Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Deutsche Bank
Tweet Send to a Friend
Deutsche Bank analyst David Hoang raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $300.00 (from $287.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
